Other topics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
== Treatments == | == Treatments == | ||
[[Enisamium_iodide|Enisamium iodide (Amizon)]] - drug profile. | [[Enisamium_iodide|Enisamium iodide (Amizon)]] - drug profile. | ||
[[Larazotide_acetate|Larazotide acetate]] - experimental drug being trialed for MIS-C. | [[Larazotide_acetate|Larazotide acetate]] - experimental drug being trialed for MIS-C. | ||
[[Prife_iTeraCare_wand|Prife iTeraCare wand]] - Controversial medical device that was sold in the vaccine injured community through multi-level marketing. | [[Prife_iTeraCare_wand|Prife iTeraCare wand]] - Controversial medical device that was sold in the vaccine injured community through multi-level marketing. | ||
Latest revision as of 04:02, 1 October 2023
Treatments[edit]
Enisamium iodide (Amizon) - drug profile.
Larazotide acetate - experimental drug being trialed for MIS-C.
Prife iTeraCare wand - Controversial medical device that was sold in the vaccine injured community through multi-level marketing.
Miscellaneous[edit]
Legal cases related to the persecution of doctors in Ontario